Author:
Hammond Sean,Meng Xiaoli,Mosedale Merrie,Naisbitt Dean J.
Funder
Otsuka Pharmaceutical Development and Commercialization Inc
UKRI
Subject
Toxicology,General Medicine
Reference15 articles.
1. Cao, X., et al., 2022. Benzodiazepine Derivatives as Potent Vasopressin V2 Receptor Antagonists for the Treatment of Autosomal Dominant Kidney Disease. 2022.
2. Therapeutic advances in ADPKD: the future awaits;Capuano;J. Nephrol.,2021
3. Tolvaptan- and Tolvaptan-metabolite-responsive T cells in patients with drug-induced liver injury;Gibson;Chem. Res. Toxicol.,2020
4. Shedding light on drug-induced liver injury: activation of T cells from drug naive human donors with tolvaptan and a hydroxybutyric acid metabolite;Hammond;Toxicol. Sci.,2021
5. Influence of chemical structure on hypersensitivity reactions induced by antiepileptic drugs: the role of the aromatic ring;Handoko;Medicine,2008